Geode Capital Management’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding OBIO
Geode Capital Management's OBIO Position: Q3 2026 in Review
Geode Capital Management reduced its Orchestra BioMed (OBIO) stake by 0.39% in Q3 2026, selling an estimated $18.7K and leaving 1,003,998 shares worth $6.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2732.
Geode Capital Management first reported a position in OBIO in Q2 2021 and has held it in 22 quarters since. 93 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.
- Geode Capital Management held 1,003,998 shares of Orchestra BioMed worth $6.25M as of Q3 2026.
- Geode Capital Management sold 3,910 Orchestra BioMed shares in Q3 2026, an estimated $18.7K.
- Orchestra BioMed made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2732 holding.
- Geode Capital Management first reported a position in Orchestra BioMed in Q2 2021 and has held it in 22 quarters since.
- 93 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.